Combined miR-486 and GP88 (Progranulin) Serum Levels Are Suggested as Supportive Biomarkers for Therapy Decision in Elderly Prostate Cancer Patients
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.